Clear Wave Wealth Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
BBA
Clear Wave Wealth Management's NRIX Position: Q3 2026 in Review
Clear Wave Wealth Management held its Nurix Therapeutics (NRIX) position steady in Q3 2026 at 10,792 shares worth $256K. The position accounts for 0.04% of the portfolio, ranked #155.
Clear Wave Wealth Management first reported a position in NRIX in Q2 2026 and has held it in 2 quarters since. The position peaked at $262K in Q2 2026. 234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.
- Clear Wave Wealth Management held 10,792 shares of Nurix Therapeutics worth $256K as of Q3 2026.
- Clear Wave Wealth Management left its Nurix Therapeutics share count unchanged in Q3 2026.
- Nurix Therapeutics made up 0.04% of Clear Wave Wealth Management's portfolio in Q3 2026, its #155 holding.
- Clear Wave Wealth Management first reported a position in Nurix Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Clear Wave Wealth Management's Nurix Therapeutics position peaked at $262K in Q2 2026.
- 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.
Based on Clear Wave Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.